![](https://porib.com/wp-content/uploads/2021/07/expert_review_of_pharmacoeconomic_and_outcomes_research.jpg)
De la Cuadra-Grande A, Rioja-Zuazu J, Domínguez-Esteban M, Torres E, Blissett R, Woodward E, Oyagüez I, Fernández-Arjona M
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system
Expert Rev Pharmacoecon Outcomes Res. 2023; vol. 23, no. 5, 499–510
![](https://porib.com/wp-content/uploads/2021/07/expert_review_of_pharmacoeconomic_and_outcomes_research.jpg)
Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MA, Menchén L
Cost-Effectiveness Analysis of Using Innovative Therapies for the Management of Moderate-To-Severe Ulcerative Colitis in Spain
Expert Rev Pharmacoecon Outcomes Res. 2021. Doi: .1080/14737167.2021.1880324
![](https://porib.com/wp-content/uploads/2021/07/expert_review_of_pharmacoeconomic_and_outcomes_research.jpg)
Gros B, Soto J, Casado MA
Incorporation of future costs in health economic analysis publications: Current situation and recommendations for the future
Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):465-9
![](https://porib.com/wp-content/uploads/2021/07/expert_review_of_pharmacoeconomic_and_outcomes_research.jpg)
Barbieri M, Drummond M, Puig-Junoy J, Casado MA, Ballina FJ, Blasco P, Poveda JL